相似文献
1
New Delhi Metallo-β-Lactamase 1 Catalyzes Avibactam and Aztreonam Hydrolysis.
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01224-17. Print 2017 Dec.
2
New Delhi metallo-β-lactamase (NDM-1): an update.
J Chemother. 2011 Oct;23(5):263-5. doi: 10.1179/joc.2011.23.5.263.
3
In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
J Infect Chemother. 2015 Feb;21(2):148-51. doi: 10.1016/j.jiac.2014.08.028. Epub 2014 Oct 25.
4
In vitro pharmacokinetics/pharmacodynamics of the combination of avibactam and aztreonam against MDR organisms.
J Antimicrob Chemother. 2016 Jul;71(7):1866-80. doi: 10.1093/jac/dkw082. Epub 2016 Apr 21.
5
The postantibiotic effect and post-β-lactamase-inhibitor effect of ceftazidime, ceftaroline and aztreonam in combination with avibactam against target Gram-negative bacteria.
Lett Appl Microbiol. 2016 Aug;63(2):96-102. doi: 10.1111/lam.12592.
6
Impaired Inhibition by Avibactam and Resistance to the Ceftazidime-Avibactam Combination Due to the DY Substitution in the KPC-2 β-Lactamase.
Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00451-17. Print 2017 Jul.
7
In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli.
Antimicrob Agents Chemother. 2015 Dec;59(12):7842-6. doi: 10.1128/AAC.02019-15. Epub 2015 Sep 21.
8
Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates.
Mol Microbiol. 2017 Nov;106(3):492-504. doi: 10.1111/mmi.13831. Epub 2017 Sep 21.
9
Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogens.
Diagn Microbiol Infect Dis. 2017 Aug;88(4):352-354. doi: 10.1016/j.diagmicrobio.2017.05.009. Epub 2017 May 18.
10
Kinetics of the interaction between avibactam and the CHE-1 class C β-lactamase.
J Antimicrob Chemother. 2015 Mar;70(3):951-3. doi: 10.1093/jac/dku442. Epub 2014 Oct 31.
引用本文的文献
1
Aztreonam-avibactam Demonstrates Potent Activity Against Carbapenem-resistant Enterobacterales Collected From US Medical Centers Over a 6-year Period (2017-2022).
Open Forum Infect Dis. 2025 Apr 25;12(5):ofaf250. doi: 10.1093/ofid/ofaf250. eCollection 2025 May.
2
Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales in a Greek Tertiary Care Hospital in Athens, 2020 to 2023.
Antibiotics (Basel). 2025 Feb 26;14(3):239. doi: 10.3390/antibiotics14030239.
3
Potentiation of Antibiotic Activity of Aztreonam against Metallo-β-Lactamase-Producing Multidrug-Resistant by 3--Substituted Difluoroquercetin Derivatives.
Pharmaceutics. 2024 Jan 28;16(2):185. doi: 10.3390/pharmaceutics16020185.
4
Treatment guidelines for multidrug-resistant Gram-negative microorganisms.
Rev Esp Quimioter. 2023 Nov;36 Suppl 1(Suppl 1):46-51. doi: 10.37201/req/s01.11.2023. Epub 2023 Nov 24.
5
Clinical outcomes in elderly patients with infections caused by NDM-producing Klebsiella pneumoniae: results from a real-life retrospective single center study in an endemic area.
Intern Emerg Med. 2023 Nov;18(8):2261-2269. doi: 10.1007/s11739-023-03416-3. Epub 2023 Sep 12.
6
Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing.
Antibiotics (Basel). 2022 May 6;11(5):628. doi: 10.3390/antibiotics11050628.
7
Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors.
Nat Chem. 2022 Jan;14(1):15-24. doi: 10.1038/s41557-021-00831-x. Epub 2021 Dec 13.
8
β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates.
RSC Med Chem. 2021 Aug 4;12(10):1623-1639. doi: 10.1039/d1md00200g. eCollection 2021 Oct 20.
9
Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases.
Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0106521. doi: 10.1128/AAC.01065-21. Epub 2021 Sep 13.
10
Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design.
Chem Rev. 2021 Jul 14;121(13):7957-8094. doi: 10.1021/acs.chemrev.1c00138. Epub 2021 Jun 15.
本文引用的文献
1
Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02243-16. Print 2017 Apr.
2
Antibiotics in late clinical development.
Biochem Pharmacol. 2017 Jun 1;133:152-163. doi: 10.1016/j.bcp.2016.09.025. Epub 2016 Sep 26.
3
Interaction of Avibactam with Class B Metallo-β-Lactamases.
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5655-62. doi: 10.1128/AAC.00897-16. Print 2016 Oct.
4
Monitoring conformational changes in the NDM-1 metallo-β-lactamase by 19F NMR spectroscopy.
Angew Chem Int Ed Engl. 2014 Mar 17;53(12):3129-33. doi: 10.1002/anie.201310866. Epub 2014 Feb 24.
5
Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-β-lactamase producers.
Antimicrob Agents Chemother. 2013 Jul;57(7):3299-306. doi: 10.1128/AAC.01989-12. Epub 2013 May 6.
6
Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae.
Int J Antimicrob Agents. 2013 Apr;41(4):325-9. doi: 10.1016/j.ijantimicag.2012.11.007. Epub 2013 Jan 8.
7
Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2009 May;53(5):1766-71. doi: 10.1128/AAC.01410-08. Epub 2009 Mar 2.
8
A minimalistic approach to identify substrate binding features in B1 Metallo-beta-lactamases.
Bioorg Med Chem Lett. 2007 Sep 15;17(18):5171-4. doi: 10.1016/j.bmcl.2007.06.089. Epub 2007 Jul 5.
9
The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
Clin Microbiol Infect. 2005 Nov;11 Suppl 6:2-9. doi: 10.1111/j.1469-0691.2005.01264.x.
10
Interaction between class B beta-lactamases and suicide substrates of active-site serine beta-lactamases.
FEBS Lett. 1999 Jan 25;443(2):109-11. doi: 10.1016/s0014-5793(98)01689-5.
Zotero 插件